PATRYS LIMITED — Director's Dealing 2025

Oct 6, 2025

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	Patrys Limited
ABN	97 123 055 363

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	James Campbell
Date of last notice	29 August 2025

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest		Direct and Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.		Barrabool Biotechnology Pty Ltd <J and KCampbell Family A/C>Dr. Campbell is a beneficiary of the aboveentity
Date of change		30 September 2025
No. of securities held prior to change		Direct:33,679,803 Fully paid ordinary shares23,389,950 Unlisted options, exercisableat $0.059 (5.9 cents), expiring on 30September 2025Indirect:2,910,125 Fully paid ordinary shares
Class		Unlisted options, exercisable at $0.059(5.9 cents), expiring on 30 September2025
Number acquired		-

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number disposed		Direct:23,389,950 Unlisted options, exercisableat $0.059 (5.9 cents), expiring on 30September 2025
Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation		Nil
No. of securities held after change		Direct:33,679,803 Fully paid ordinary sharesIndirect:2,910,125 Fully paid ordinary shares
Nature of changeExample: on-market trade, off-market trade, exercise of options, issueof securities under dividend reinvestment plan, participation in buy-back		Expiry of Unlisted options.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder(if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interestrelated prior to changeNote: Details are only required for a contract in relation to which theinterest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/ConsiderationNote: If consideration is non-cash, provide details and an estimatedvaluation	N/A
Interest after change	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts	No
detailed above traded during a+closed period
where prior written clearance was required?
If so, was prior written clearance provided to	N/A
allow the trade to proceed during this period?
If prior written clearance was provided, on what	N/A
date was this provided?

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 3